LT - REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE
EN - REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
(51) |
INT.CL. |
C12N 5/0783 |
(2010.01) |
|
|
A61K 39/0008 |
(2013.01) |
|
|
A61K 39/00 |
(2006.01) |
|
|
A61K 39/0011 |
(2013.01) |
|
|
A61P 29/00 |
(2006.01) |
|
|
C12N 5/0636 |
(2013.01) |
|
|
A61P 37/00 |
(2006.01) |
|
|
A61P 29/00 |
(2018.01) |
|
|
A61P 37/00 |
(2018.01) |
Europos patentas
(11) |
Patento numeris |
3097923 |
(13) |
Dokumento rūšis |
T |
(96) |
Europos patento paraiškos numeris |
16177278.5 |
|
Europos patento paraiškos padavimo data |
2008-01-31 |
(97) |
Europos patento paraiškos paskelbimo data |
2016-11-30 |
(45) |
Paskelbimo apie Europos patento išdavimą data |
2022-07-27
|
(46) |
Apibrėžties vertimo paskelbimo data |
|
Prioriteto paraiškos
(30) |
Numeris |
Data |
Šalis |
|
898408 P |
2007-01-31
|
US |
|
951052 P |
2007-07-20
|
US |
Išradėjai
(72) |
ESHHAR, Zelig , IL
ELINAV, Eran , IL
|
Savininkas
(73) |
YEDA RESEARCH AND
DEVELOPMENT CO., LTD. ,
The Weizmann Institute of Science,
P.O. Box 95, 76100 Rehovot,
IL
|
Pavadinimas
(54) |
REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE |
|
REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE |